About the Authors
- Craig I. Coleman
-
* E-mail: craig.coleman@hhchealth.org
Affiliation University of Connecticut School of Pharmacy, Storrs, Connecticut, United States of America
- Muralikrishna Tangirala
-
Affiliation Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, United States of America
- Thomas Evers
-
Affiliation Bayer Pharma AG, Wuppertal, Germany
Competing Interests
The authors have the following interests. Funding for this study was provided by Bayer HealthCare Pharmaceuticals and Janssen Scientific Affairs, LLC. Muralikrishna Tangirala is employed by Bayer HealthCare Pharmaceuticals and Thomas Evers by Bayer Pharma AG. Rivaroxaban is manufactured by Bayer. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: CC MT TE. Performed the experiments: MT. Analyzed the data: MT. Wrote the paper: CC MT TE.